Gavi Makes Deal With J&J on COVID-19 Vaccines; WHO Says COVID-19 Deaths Could Be 2-3 Times Higher Than 3.2 Million Reported 21/05/2021 Kerry Cullinan Johnson & Johnson will supply COVAX 200 million of its single-dose COVID-19 vaccines by the end of the year, according to a statement on Friday by Gavi, the Vaccine Alliance, announcing the advance purchase agreement. The vaccine will be available to both COVAX members who buy their own vaccines and the COVAX AMC members. “Today’s […] Continue reading -> As Gaza-Israel Cease-Fire Looms, WHO Officials Warn That Conflict’s Embers Could Reignite A New Wave Of COVID-19 21/05/2021 Madeleine Hoecklin The hostilities between Israel and Hamas over the past 10 days have caused significant damage to the health system in Gaza, putting the Palestinian population at risk of increased spread of COVID-19 – after six weeks in which new cases had been in sharp decline. The health system in Gaza is now facing severe shortages […] Continue reading -> ‘IP Monopoly Capitalism’ – A ‘Virus’ To Society During COVID-19 19/05/2021 Raisa Santos Governments and pharmaceutical companies alike must work together in combating the ‘virus of intellectual property (IP) monopolies over COVID-19 vaccines – which further exacerbates inequality and lack of access to vaccines for vulnerable groups. That was the uptake of a group of experts speaking at a webinar Wednesday on “The Virus of IP Monopoly Capitalism”’ […] Continue reading -> Sanofi-GSK Position SARS-CoV2 Candidate Vaccine as Potential ‘Booster’ 18/05/2021 Kerry Cullinan Sanofi and GSK will test their two-dose SARS-CoV2 vaccine candidate as a booster for other vaccines during its phase 3 trial, following a phase 2 trial that showed that it triggered a strong neutralizing antibody response in people previously vaccinated. Those who had already been vaccinated showed a strong response after one jab, indicating that […] Continue reading -> Delaying Second Pfizer COVID-19 Vaccine Dose Increases Antibody Response Threefold In Over-80s, Study Finds 14/05/2021 Madeleine Hoecklin Delaying the second dose of the Pfizer/BioNTech COVID-19 vaccine by 12 weeks could generate antibody responses in those over the age of 80 more than threefold, found a pre-print study published on Friday. The study, conducted by the University of Birmingham and Public Health England, is the first to directly compare the immune response derived […] Continue reading -> Top Scientists Call For Further Investigation Into Virus Origins Ahead Of World Health Assembly 14/05/2021 Madeleine Hoecklin A group of 18 prominent scientists, primarily based in the United States, have called for further investigations into the origins of the SARS-CoV2 virus, including that it could have been created in the Wuhan Institute of Virology lab, in a letter published on Thursday in the journal Science. The letter, organised by David Relman, Professor […] Continue reading -> Impact of COVID-19 on African Continent Underestimated, Says New Report 12/05/2021 Raisa Santos Limitations in COVID-19 testing capacity and surveillance—as well as uneven demand for testing—are likely masking the true severity of COVID-19 on the African continent, fueling the dangerous myth that much of Africa has been unscathed by COVID-19. Test positivity rates were above 10% across many African Union (AU) member states during the second wave—substantially higher […] Continue reading -> Company Pushes Canada to Grant Compulsory License for Johnson & Johnson COVID-19 Vaccine 11/05/2021 Kerry Cullinan A Canadian pharmaceutical company, Biolyse, has agreed to provide Bolivia with 15 million doses of the Johnson & Johnson COVID-19 vaccine – as long as the Canadian government gives it a compulsory license to manufacture the vaccine. In March, Johnson & Johnson rejected an application by Biolyse for a voluntary license to make a generic […] Continue reading -> Pandemic Treaty Proposal to go before WHO Member States this Week 10/05/2021 Kerry Cullinan The draft of a landmark resolution to establish a global “Pandemic Treaty” will be put to World Health Organization (WHO) member states this week in preparation for the World Health Assembly beginning 24 May, Jaouad Mahjour, WHO Assistant Director-General Emergency Preparedness, told a panel in Geneva Monday. The proposal for the Pandemic Treaty – […] Continue reading -> WHO Calls For Pharma Transparency In Clinical Trial Data Reporting 07/05/2021 Elaine Ruth Fletcher In a far-reaching statement, WHO and the International Coalition of Medicines Regulatory Authorities (ICMRA) called on the pharma industry to provide much wider access to clinical data for all new medicines and vaccines approved, or under review, and even those that had been rejected. “Clinical trial reports should be published without redaction of confidential information […] Continue reading -> Posts navigation Older postsNewer posts
As Gaza-Israel Cease-Fire Looms, WHO Officials Warn That Conflict’s Embers Could Reignite A New Wave Of COVID-19 21/05/2021 Madeleine Hoecklin The hostilities between Israel and Hamas over the past 10 days have caused significant damage to the health system in Gaza, putting the Palestinian population at risk of increased spread of COVID-19 – after six weeks in which new cases had been in sharp decline. The health system in Gaza is now facing severe shortages […] Continue reading -> ‘IP Monopoly Capitalism’ – A ‘Virus’ To Society During COVID-19 19/05/2021 Raisa Santos Governments and pharmaceutical companies alike must work together in combating the ‘virus of intellectual property (IP) monopolies over COVID-19 vaccines – which further exacerbates inequality and lack of access to vaccines for vulnerable groups. That was the uptake of a group of experts speaking at a webinar Wednesday on “The Virus of IP Monopoly Capitalism”’ […] Continue reading -> Sanofi-GSK Position SARS-CoV2 Candidate Vaccine as Potential ‘Booster’ 18/05/2021 Kerry Cullinan Sanofi and GSK will test their two-dose SARS-CoV2 vaccine candidate as a booster for other vaccines during its phase 3 trial, following a phase 2 trial that showed that it triggered a strong neutralizing antibody response in people previously vaccinated. Those who had already been vaccinated showed a strong response after one jab, indicating that […] Continue reading -> Delaying Second Pfizer COVID-19 Vaccine Dose Increases Antibody Response Threefold In Over-80s, Study Finds 14/05/2021 Madeleine Hoecklin Delaying the second dose of the Pfizer/BioNTech COVID-19 vaccine by 12 weeks could generate antibody responses in those over the age of 80 more than threefold, found a pre-print study published on Friday. The study, conducted by the University of Birmingham and Public Health England, is the first to directly compare the immune response derived […] Continue reading -> Top Scientists Call For Further Investigation Into Virus Origins Ahead Of World Health Assembly 14/05/2021 Madeleine Hoecklin A group of 18 prominent scientists, primarily based in the United States, have called for further investigations into the origins of the SARS-CoV2 virus, including that it could have been created in the Wuhan Institute of Virology lab, in a letter published on Thursday in the journal Science. The letter, organised by David Relman, Professor […] Continue reading -> Impact of COVID-19 on African Continent Underestimated, Says New Report 12/05/2021 Raisa Santos Limitations in COVID-19 testing capacity and surveillance—as well as uneven demand for testing—are likely masking the true severity of COVID-19 on the African continent, fueling the dangerous myth that much of Africa has been unscathed by COVID-19. Test positivity rates were above 10% across many African Union (AU) member states during the second wave—substantially higher […] Continue reading -> Company Pushes Canada to Grant Compulsory License for Johnson & Johnson COVID-19 Vaccine 11/05/2021 Kerry Cullinan A Canadian pharmaceutical company, Biolyse, has agreed to provide Bolivia with 15 million doses of the Johnson & Johnson COVID-19 vaccine – as long as the Canadian government gives it a compulsory license to manufacture the vaccine. In March, Johnson & Johnson rejected an application by Biolyse for a voluntary license to make a generic […] Continue reading -> Pandemic Treaty Proposal to go before WHO Member States this Week 10/05/2021 Kerry Cullinan The draft of a landmark resolution to establish a global “Pandemic Treaty” will be put to World Health Organization (WHO) member states this week in preparation for the World Health Assembly beginning 24 May, Jaouad Mahjour, WHO Assistant Director-General Emergency Preparedness, told a panel in Geneva Monday. The proposal for the Pandemic Treaty – […] Continue reading -> WHO Calls For Pharma Transparency In Clinical Trial Data Reporting 07/05/2021 Elaine Ruth Fletcher In a far-reaching statement, WHO and the International Coalition of Medicines Regulatory Authorities (ICMRA) called on the pharma industry to provide much wider access to clinical data for all new medicines and vaccines approved, or under review, and even those that had been rejected. “Clinical trial reports should be published without redaction of confidential information […] Continue reading -> Posts navigation Older postsNewer posts
‘IP Monopoly Capitalism’ – A ‘Virus’ To Society During COVID-19 19/05/2021 Raisa Santos Governments and pharmaceutical companies alike must work together in combating the ‘virus of intellectual property (IP) monopolies over COVID-19 vaccines – which further exacerbates inequality and lack of access to vaccines for vulnerable groups. That was the uptake of a group of experts speaking at a webinar Wednesday on “The Virus of IP Monopoly Capitalism”’ […] Continue reading -> Sanofi-GSK Position SARS-CoV2 Candidate Vaccine as Potential ‘Booster’ 18/05/2021 Kerry Cullinan Sanofi and GSK will test their two-dose SARS-CoV2 vaccine candidate as a booster for other vaccines during its phase 3 trial, following a phase 2 trial that showed that it triggered a strong neutralizing antibody response in people previously vaccinated. Those who had already been vaccinated showed a strong response after one jab, indicating that […] Continue reading -> Delaying Second Pfizer COVID-19 Vaccine Dose Increases Antibody Response Threefold In Over-80s, Study Finds 14/05/2021 Madeleine Hoecklin Delaying the second dose of the Pfizer/BioNTech COVID-19 vaccine by 12 weeks could generate antibody responses in those over the age of 80 more than threefold, found a pre-print study published on Friday. The study, conducted by the University of Birmingham and Public Health England, is the first to directly compare the immune response derived […] Continue reading -> Top Scientists Call For Further Investigation Into Virus Origins Ahead Of World Health Assembly 14/05/2021 Madeleine Hoecklin A group of 18 prominent scientists, primarily based in the United States, have called for further investigations into the origins of the SARS-CoV2 virus, including that it could have been created in the Wuhan Institute of Virology lab, in a letter published on Thursday in the journal Science. The letter, organised by David Relman, Professor […] Continue reading -> Impact of COVID-19 on African Continent Underestimated, Says New Report 12/05/2021 Raisa Santos Limitations in COVID-19 testing capacity and surveillance—as well as uneven demand for testing—are likely masking the true severity of COVID-19 on the African continent, fueling the dangerous myth that much of Africa has been unscathed by COVID-19. Test positivity rates were above 10% across many African Union (AU) member states during the second wave—substantially higher […] Continue reading -> Company Pushes Canada to Grant Compulsory License for Johnson & Johnson COVID-19 Vaccine 11/05/2021 Kerry Cullinan A Canadian pharmaceutical company, Biolyse, has agreed to provide Bolivia with 15 million doses of the Johnson & Johnson COVID-19 vaccine – as long as the Canadian government gives it a compulsory license to manufacture the vaccine. In March, Johnson & Johnson rejected an application by Biolyse for a voluntary license to make a generic […] Continue reading -> Pandemic Treaty Proposal to go before WHO Member States this Week 10/05/2021 Kerry Cullinan The draft of a landmark resolution to establish a global “Pandemic Treaty” will be put to World Health Organization (WHO) member states this week in preparation for the World Health Assembly beginning 24 May, Jaouad Mahjour, WHO Assistant Director-General Emergency Preparedness, told a panel in Geneva Monday. The proposal for the Pandemic Treaty – […] Continue reading -> WHO Calls For Pharma Transparency In Clinical Trial Data Reporting 07/05/2021 Elaine Ruth Fletcher In a far-reaching statement, WHO and the International Coalition of Medicines Regulatory Authorities (ICMRA) called on the pharma industry to provide much wider access to clinical data for all new medicines and vaccines approved, or under review, and even those that had been rejected. “Clinical trial reports should be published without redaction of confidential information […] Continue reading -> Posts navigation Older postsNewer posts
Sanofi-GSK Position SARS-CoV2 Candidate Vaccine as Potential ‘Booster’ 18/05/2021 Kerry Cullinan Sanofi and GSK will test their two-dose SARS-CoV2 vaccine candidate as a booster for other vaccines during its phase 3 trial, following a phase 2 trial that showed that it triggered a strong neutralizing antibody response in people previously vaccinated. Those who had already been vaccinated showed a strong response after one jab, indicating that […] Continue reading -> Delaying Second Pfizer COVID-19 Vaccine Dose Increases Antibody Response Threefold In Over-80s, Study Finds 14/05/2021 Madeleine Hoecklin Delaying the second dose of the Pfizer/BioNTech COVID-19 vaccine by 12 weeks could generate antibody responses in those over the age of 80 more than threefold, found a pre-print study published on Friday. The study, conducted by the University of Birmingham and Public Health England, is the first to directly compare the immune response derived […] Continue reading -> Top Scientists Call For Further Investigation Into Virus Origins Ahead Of World Health Assembly 14/05/2021 Madeleine Hoecklin A group of 18 prominent scientists, primarily based in the United States, have called for further investigations into the origins of the SARS-CoV2 virus, including that it could have been created in the Wuhan Institute of Virology lab, in a letter published on Thursday in the journal Science. The letter, organised by David Relman, Professor […] Continue reading -> Impact of COVID-19 on African Continent Underestimated, Says New Report 12/05/2021 Raisa Santos Limitations in COVID-19 testing capacity and surveillance—as well as uneven demand for testing—are likely masking the true severity of COVID-19 on the African continent, fueling the dangerous myth that much of Africa has been unscathed by COVID-19. Test positivity rates were above 10% across many African Union (AU) member states during the second wave—substantially higher […] Continue reading -> Company Pushes Canada to Grant Compulsory License for Johnson & Johnson COVID-19 Vaccine 11/05/2021 Kerry Cullinan A Canadian pharmaceutical company, Biolyse, has agreed to provide Bolivia with 15 million doses of the Johnson & Johnson COVID-19 vaccine – as long as the Canadian government gives it a compulsory license to manufacture the vaccine. In March, Johnson & Johnson rejected an application by Biolyse for a voluntary license to make a generic […] Continue reading -> Pandemic Treaty Proposal to go before WHO Member States this Week 10/05/2021 Kerry Cullinan The draft of a landmark resolution to establish a global “Pandemic Treaty” will be put to World Health Organization (WHO) member states this week in preparation for the World Health Assembly beginning 24 May, Jaouad Mahjour, WHO Assistant Director-General Emergency Preparedness, told a panel in Geneva Monday. The proposal for the Pandemic Treaty – […] Continue reading -> WHO Calls For Pharma Transparency In Clinical Trial Data Reporting 07/05/2021 Elaine Ruth Fletcher In a far-reaching statement, WHO and the International Coalition of Medicines Regulatory Authorities (ICMRA) called on the pharma industry to provide much wider access to clinical data for all new medicines and vaccines approved, or under review, and even those that had been rejected. “Clinical trial reports should be published without redaction of confidential information […] Continue reading -> Posts navigation Older postsNewer posts
Delaying Second Pfizer COVID-19 Vaccine Dose Increases Antibody Response Threefold In Over-80s, Study Finds 14/05/2021 Madeleine Hoecklin Delaying the second dose of the Pfizer/BioNTech COVID-19 vaccine by 12 weeks could generate antibody responses in those over the age of 80 more than threefold, found a pre-print study published on Friday. The study, conducted by the University of Birmingham and Public Health England, is the first to directly compare the immune response derived […] Continue reading -> Top Scientists Call For Further Investigation Into Virus Origins Ahead Of World Health Assembly 14/05/2021 Madeleine Hoecklin A group of 18 prominent scientists, primarily based in the United States, have called for further investigations into the origins of the SARS-CoV2 virus, including that it could have been created in the Wuhan Institute of Virology lab, in a letter published on Thursday in the journal Science. The letter, organised by David Relman, Professor […] Continue reading -> Impact of COVID-19 on African Continent Underestimated, Says New Report 12/05/2021 Raisa Santos Limitations in COVID-19 testing capacity and surveillance—as well as uneven demand for testing—are likely masking the true severity of COVID-19 on the African continent, fueling the dangerous myth that much of Africa has been unscathed by COVID-19. Test positivity rates were above 10% across many African Union (AU) member states during the second wave—substantially higher […] Continue reading -> Company Pushes Canada to Grant Compulsory License for Johnson & Johnson COVID-19 Vaccine 11/05/2021 Kerry Cullinan A Canadian pharmaceutical company, Biolyse, has agreed to provide Bolivia with 15 million doses of the Johnson & Johnson COVID-19 vaccine – as long as the Canadian government gives it a compulsory license to manufacture the vaccine. In March, Johnson & Johnson rejected an application by Biolyse for a voluntary license to make a generic […] Continue reading -> Pandemic Treaty Proposal to go before WHO Member States this Week 10/05/2021 Kerry Cullinan The draft of a landmark resolution to establish a global “Pandemic Treaty” will be put to World Health Organization (WHO) member states this week in preparation for the World Health Assembly beginning 24 May, Jaouad Mahjour, WHO Assistant Director-General Emergency Preparedness, told a panel in Geneva Monday. The proposal for the Pandemic Treaty – […] Continue reading -> WHO Calls For Pharma Transparency In Clinical Trial Data Reporting 07/05/2021 Elaine Ruth Fletcher In a far-reaching statement, WHO and the International Coalition of Medicines Regulatory Authorities (ICMRA) called on the pharma industry to provide much wider access to clinical data for all new medicines and vaccines approved, or under review, and even those that had been rejected. “Clinical trial reports should be published without redaction of confidential information […] Continue reading -> Posts navigation Older postsNewer posts
Top Scientists Call For Further Investigation Into Virus Origins Ahead Of World Health Assembly 14/05/2021 Madeleine Hoecklin A group of 18 prominent scientists, primarily based in the United States, have called for further investigations into the origins of the SARS-CoV2 virus, including that it could have been created in the Wuhan Institute of Virology lab, in a letter published on Thursday in the journal Science. The letter, organised by David Relman, Professor […] Continue reading -> Impact of COVID-19 on African Continent Underestimated, Says New Report 12/05/2021 Raisa Santos Limitations in COVID-19 testing capacity and surveillance—as well as uneven demand for testing—are likely masking the true severity of COVID-19 on the African continent, fueling the dangerous myth that much of Africa has been unscathed by COVID-19. Test positivity rates were above 10% across many African Union (AU) member states during the second wave—substantially higher […] Continue reading -> Company Pushes Canada to Grant Compulsory License for Johnson & Johnson COVID-19 Vaccine 11/05/2021 Kerry Cullinan A Canadian pharmaceutical company, Biolyse, has agreed to provide Bolivia with 15 million doses of the Johnson & Johnson COVID-19 vaccine – as long as the Canadian government gives it a compulsory license to manufacture the vaccine. In March, Johnson & Johnson rejected an application by Biolyse for a voluntary license to make a generic […] Continue reading -> Pandemic Treaty Proposal to go before WHO Member States this Week 10/05/2021 Kerry Cullinan The draft of a landmark resolution to establish a global “Pandemic Treaty” will be put to World Health Organization (WHO) member states this week in preparation for the World Health Assembly beginning 24 May, Jaouad Mahjour, WHO Assistant Director-General Emergency Preparedness, told a panel in Geneva Monday. The proposal for the Pandemic Treaty – […] Continue reading -> WHO Calls For Pharma Transparency In Clinical Trial Data Reporting 07/05/2021 Elaine Ruth Fletcher In a far-reaching statement, WHO and the International Coalition of Medicines Regulatory Authorities (ICMRA) called on the pharma industry to provide much wider access to clinical data for all new medicines and vaccines approved, or under review, and even those that had been rejected. “Clinical trial reports should be published without redaction of confidential information […] Continue reading -> Posts navigation Older postsNewer posts
Impact of COVID-19 on African Continent Underestimated, Says New Report 12/05/2021 Raisa Santos Limitations in COVID-19 testing capacity and surveillance—as well as uneven demand for testing—are likely masking the true severity of COVID-19 on the African continent, fueling the dangerous myth that much of Africa has been unscathed by COVID-19. Test positivity rates were above 10% across many African Union (AU) member states during the second wave—substantially higher […] Continue reading -> Company Pushes Canada to Grant Compulsory License for Johnson & Johnson COVID-19 Vaccine 11/05/2021 Kerry Cullinan A Canadian pharmaceutical company, Biolyse, has agreed to provide Bolivia with 15 million doses of the Johnson & Johnson COVID-19 vaccine – as long as the Canadian government gives it a compulsory license to manufacture the vaccine. In March, Johnson & Johnson rejected an application by Biolyse for a voluntary license to make a generic […] Continue reading -> Pandemic Treaty Proposal to go before WHO Member States this Week 10/05/2021 Kerry Cullinan The draft of a landmark resolution to establish a global “Pandemic Treaty” will be put to World Health Organization (WHO) member states this week in preparation for the World Health Assembly beginning 24 May, Jaouad Mahjour, WHO Assistant Director-General Emergency Preparedness, told a panel in Geneva Monday. The proposal for the Pandemic Treaty – […] Continue reading -> WHO Calls For Pharma Transparency In Clinical Trial Data Reporting 07/05/2021 Elaine Ruth Fletcher In a far-reaching statement, WHO and the International Coalition of Medicines Regulatory Authorities (ICMRA) called on the pharma industry to provide much wider access to clinical data for all new medicines and vaccines approved, or under review, and even those that had been rejected. “Clinical trial reports should be published without redaction of confidential information […] Continue reading -> Posts navigation Older postsNewer posts
Company Pushes Canada to Grant Compulsory License for Johnson & Johnson COVID-19 Vaccine 11/05/2021 Kerry Cullinan A Canadian pharmaceutical company, Biolyse, has agreed to provide Bolivia with 15 million doses of the Johnson & Johnson COVID-19 vaccine – as long as the Canadian government gives it a compulsory license to manufacture the vaccine. In March, Johnson & Johnson rejected an application by Biolyse for a voluntary license to make a generic […] Continue reading -> Pandemic Treaty Proposal to go before WHO Member States this Week 10/05/2021 Kerry Cullinan The draft of a landmark resolution to establish a global “Pandemic Treaty” will be put to World Health Organization (WHO) member states this week in preparation for the World Health Assembly beginning 24 May, Jaouad Mahjour, WHO Assistant Director-General Emergency Preparedness, told a panel in Geneva Monday. The proposal for the Pandemic Treaty – […] Continue reading -> WHO Calls For Pharma Transparency In Clinical Trial Data Reporting 07/05/2021 Elaine Ruth Fletcher In a far-reaching statement, WHO and the International Coalition of Medicines Regulatory Authorities (ICMRA) called on the pharma industry to provide much wider access to clinical data for all new medicines and vaccines approved, or under review, and even those that had been rejected. “Clinical trial reports should be published without redaction of confidential information […] Continue reading -> Posts navigation Older postsNewer posts
Pandemic Treaty Proposal to go before WHO Member States this Week 10/05/2021 Kerry Cullinan The draft of a landmark resolution to establish a global “Pandemic Treaty” will be put to World Health Organization (WHO) member states this week in preparation for the World Health Assembly beginning 24 May, Jaouad Mahjour, WHO Assistant Director-General Emergency Preparedness, told a panel in Geneva Monday. The proposal for the Pandemic Treaty – […] Continue reading -> WHO Calls For Pharma Transparency In Clinical Trial Data Reporting 07/05/2021 Elaine Ruth Fletcher In a far-reaching statement, WHO and the International Coalition of Medicines Regulatory Authorities (ICMRA) called on the pharma industry to provide much wider access to clinical data for all new medicines and vaccines approved, or under review, and even those that had been rejected. “Clinical trial reports should be published without redaction of confidential information […] Continue reading -> Posts navigation Older postsNewer posts
WHO Calls For Pharma Transparency In Clinical Trial Data Reporting 07/05/2021 Elaine Ruth Fletcher In a far-reaching statement, WHO and the International Coalition of Medicines Regulatory Authorities (ICMRA) called on the pharma industry to provide much wider access to clinical data for all new medicines and vaccines approved, or under review, and even those that had been rejected. “Clinical trial reports should be published without redaction of confidential information […] Continue reading -> Posts navigation Older postsNewer posts